Could a shot every 6 months end HIV? new study tests lenacapavir in south africa
Prevention
Not yet recruiting
This study will offer young people aged 15-35 in Cape Town a choice of HIV prevention methods: a new twice-yearly injection (lenacapavir), a two-monthly injection (cabotegravir), or daily pills. Researchers want to see which option people stick with over 18 months and how best to…
Sponsor: Desmond Tutu HIV Foundation • Aim: Prevention
Last updated Jun 27, 2026 09:02 UTC